代谢与心血管疾病论坛-4
Metabolic & CVD Forum-4
Metabolic & CVD Forum-4
2025年11月22日 星期六
|
13:30-15:30 102A |
|---|
| 主持 Moderators | 谢小洁 Xiaojie XIE, 张岩 Yan ZHANG, 王胜煌 Shenghuang WANG | ||
| 讨论嘉宾 Discussants | John R. Nelson, 李建平 Jianping LI, 阮雄中 Xiongzhong RUAN, 李建军 Jianjun LI | ||
|
13:30-13:35 |
致辞 Opening Remarks |
定 待 | |
|
13:35-14:00 |
中外论道：聚焦国内外最新血脂前沿 1、ASCVD剩留风险的现状和研究进展 2、剩留风险的评估指标 3、剩留风险的靶点和新药研究 Sino-Foreign Dialogue: Focus on the Latest Domestic and International Lipid Frontiers 1. Current Status and Research Progress of ASCVD Residual Risk 2. Evaluation Indicators of Residual Risk 3. Targets and New Drug Research for Residual Risk |
||
|
14:00-14:20 |
降低高甘油三酯血症患者的残余心血管风险：二十碳五烯酸的独特作用 Reducing Residual Cardiovascular Risk in Patients with Hypertriglyceridemia: the Unique Role of Eicosapentaenoic acid |
John R. Nelson | |
|
14:20-14:40 |
降脂新药研究进展 Research Progress of New Lipid-Lowering Drugs |
李建平 Jianping LI | |
|
14:40-15:00 |
代谢共病的脂代谢特点与临床对策 Lipid Metabolism Characteristics and Clinical Countermeasures of Metabolic Comorbidities |
阮雄中 Xiongzhong RUAN | |
|
15:00-15:20 |
VAP技术检测血脂与脂蛋白亚组分及其临床应用中国专家共识（2025版）解读 Interpretation of the Chinese Expert Consensus on the Detection of Blood Lipids and Lipoprotein Subfractions by VAP Technology and Their Clinical Application (2025 Edition) |
鄢盛恺 Shengkai YAN | |
|
15:20-15:30 |
总结 Summary |
||